Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 22 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (6)
Early P 1 (1)
P 1 (4)
P 2 (8)
P 3 (2)
P 4 (1)

Trial Status

Completed7
Recruiting7
Not Yet Recruiting6
Enrolling By Invitation1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT07551271Not ApplicableCompletedPrimary

Clinical Study of PRP in the Treatment of Androgenetic Alopecia

NCT07536100Not ApplicableNot Yet RecruitingPrimary

VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia

NCT07529977Phase 3Not Yet Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

NCT07335367Phase 2RecruitingPrimary

PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study

NCT06648850Phase 2Not Yet Recruiting

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

NCT07518342Phase 4Not Yet Recruiting

The Effect of Nanofat Injection on Androgenetic Alopecia

NCT07370519Phase 2RecruitingPrimary

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

NCT07327359Phase 1RecruitingPrimary

A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

NCT07076706Phase 2Completed

Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

NCT07412587Not ApplicableCompletedPrimary

Therapeutic Potential of Topical Latanoprost Acid in Hair Loss - Pilot, Proof-of-concept Study

NCT07358403Not ApplicableCompletedPrimary

Evaluation of the Dietary Supplement Efficacy Against Hair Loss in Subjects Suffering From Hair Loss

NCT07317544Phase 1RecruitingPrimary

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

NCT07146022Phase 3RecruitingPrimary

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

NCT07079657Not ApplicableRecruitingPrimary

Thulium Laser and Growth Factors for Androgenetic Alopecia

NCT07038941Phase 1Completed

Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

NCT07018349Not ApplicableNot Yet RecruitingPrimary

Low Dose Oral Minoxdil in Androgenic Alopecia

NCT07012486Early Phase 1RecruitingPrimary

Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia

NCT07011485Phase 2Active Not Recruiting

A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.

NCT06764329Phase 1Enrolling By Invitation

The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.

NCT06622824Phase 2Not Yet RecruitingPrimary

To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia

Scroll to load more

Research Network

Activity Timeline